227 related articles for article (PubMed ID: 8613740)
1. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal.
Aley KO; Green PG; Levine JD
J Neurosci; 1995 Dec; 15(12):8031-8. PubMed ID: 8613740
[TBL] [Abstract][Full Text] [Related]
2. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
Aley KO; Levine JD
J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of tolerance and dependence for opioid peripheral antinociception in rats.
Aley KO; Levine JD
J Neurosci; 1997 May; 17(10):3907-12. PubMed ID: 9133408
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat.
Aley KO; Levine JD
J Neurosci; 1997 Oct; 17(20):8018-23. PubMed ID: 9315920
[TBL] [Abstract][Full Text] [Related]
5. Mu-opioid agonist enhancement of prostaglandin-induced hyperalgesia in the rat: a G-protein beta gamma subunit-mediated effect?
Khasar SG; Wang JF; Taiwo YO; Heller PH; Green PG; Levine JD
Neuroscience; 1995 Jul; 67(1):189-95. PubMed ID: 7477899
[TBL] [Abstract][Full Text] [Related]
6. Effects of mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats.
Vivian JA; Miczek KA
Psychopharmacology (Berl); 1998 Oct; 139(4):364-75. PubMed ID: 9809857
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
8. DAMGO in the central amygdala alleviates the affective dimension of pain in a rat model of inflammatory hyperalgesia.
Zhang RX; Zhang M; Li A; Pan L; Berman BM; Ren K; Lao L
Neuroscience; 2013 Nov; 252():359-66. PubMed ID: 23994597
[TBL] [Abstract][Full Text] [Related]
9. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
10. Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors.
Khasar SG; McCarter G; Levine JD
J Neurophysiol; 1999 Mar; 81(3):1104-12. PubMed ID: 10085337
[TBL] [Abstract][Full Text] [Related]
11. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
12. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
13. Temporal dissociation of recovery from antinociceptive and motor effects following intrathecal administration of a selective mu-opioid agonist.
Miaskowski C; Franck LS; Putris J; Levine JD
Nurs Res; 1993; 42(6):344-8. PubMed ID: 8247817
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction between purinergic system and opioid withdrawal: in vitro evidence.
Capasso A; Gallo C
Curr Drug Saf; 2009 May; 4(2):97-102. PubMed ID: 19442100
[TBL] [Abstract][Full Text] [Related]
15. Comparison of intradermal and subcutaneous hyperalgesic effects of inflammatory mediators in the rat.
Khasar SG; Green PG; Levine JD
Neurosci Lett; 1993 Apr; 153(2):215-8. PubMed ID: 8100992
[TBL] [Abstract][Full Text] [Related]
16. The intrathecal administration of excitatory amino acid receptor antagonists selectively attenuated carrageenan-induced behavioral hyperalgesia in rats.
Ren K; Williams GM; Hylden JL; Ruda MA; Dubner R
Eur J Pharmacol; 1992 Aug; 219(2):235-43. PubMed ID: 1358641
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
[TBL] [Abstract][Full Text] [Related]
18. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist--loperamide.
Nozaki-Taguchi N; Yaksh TL
Anesthesiology; 1999 Jan; 90(1):225-34. PubMed ID: 9915332
[TBL] [Abstract][Full Text] [Related]
20. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice.
Bilsky EJ; Inturrisi CE; Sadée W; Hruby VJ; Porreca F
Pain; 1996 Dec; 68(2-3):229-37. PubMed ID: 9121809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
